Biogen Mulling Bid for Ireland's Elan (Reuters) Reuters - U.S. drug company Biogen Idec\is considering an all-share bid of more than 8.5 billion euros\( #36;10.6 billion) for Irish peer Elan, a newspaper reported on\Sunday.